Adragos Pharma Acquires Baccinex

Lonza Group AG Acquires Synaffix B.V.

June 1, 2023

Biotechnology

Lonza Group AG has acquired Synaffix B.V., a Netherlands-based biotech company that commercialises a clinical-stage antibody-drug conjugate (ADC) technology platform. The deal brings Synaffix's ADC bioconjugation technology into Lonza's integrated ADC development and manufacturing offering to accelerate discovery, development, scale-up and commercialization of ADCs.

Myonex Acquires Creapharm's Pharmaceutical Services Business

May 2, 2024

Pharmaceuticals

Myonex has completed the acquisition of Creapharm's pharmaceutical services business, integrating Creapharm's clinical packaging, commercial packaging and bioservices into its global clinical trial supply platform. The deal brings Creapharm's cold-chain and ultra-cold capabilities and expands Myonex's service offering and European footprint; Creapharm founder Eric Placet has reinvested and joined the Myonex board.

Astorg Acquires Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022

Pharmaceuticals

Astorg has signed a binding agreement to acquire CordenPharma, a global contract development and manufacturing organization (CDMO) focused on APIs, excipients and drug products, from International Chemical Investors Group (ICIG). CordenPharma employs over 2,600 people across 11 manufacturing sites and an R&D laboratory in Europe and the US; the founders will reinvest alongside Astorg. The transaction is subject to customary regulatory approvals and terms were not disclosed.

Zydus Lifesciences Acquires Agenus' U.S. Biologics Manufacturing Facilities and Launches Zylidac Bio LLC

January 16, 2026

Biotechnology

Zydus Lifesciences Limited has completed purchase agreements with Agenus Inc. to acquire Agenus' biologics manufacturing facilities and operations in Emeryville and Berkeley, California, and has established a U.S. CDMO subsidiary, Zylidac Bio LLC, to operate the assets. The deal includes exclusive manufacturing arrangements for Agenus' Phase 3 immuno-oncology candidates (botensilimab and balstilimab), exclusive commercialization rights for those assets in India and Sri Lanka, and an equity investment in Agenus via Zynext Ventures; regulatory approvals including CFIUS clearance were secured.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.

APNAR Pharma Acquires Aurex Laboratories

February 3, 2022

Pharmaceuticals

APNAR Pharma LP, a privately owned pharmaceutical company based in Chino, California, has acquired East Windsor, New Jersey–based Aurex Laboratories. The deal adds US FDA–approved finished dosage manufacturing capabilities to APNAR’s platform, expanding its U.S. footprint, pipeline capacity and contract manufacturing capabilities to support APNAR’s ANDAs and third‑party partners.